New alliance converts AI-powered fan intelligence and travel experiences into incremental revenue for major sporting events and host cities worldwide San Francisco, CA — DataCurve, the leading fan intelligence and…
AI isn’t coming soon—it’s here, and it’s upending what it means to compete and thrive in today’s economy. Michael K Bender’s new book, AI at Work: Turning Uncertainty into Opportunity…
United States — A subtle but meaningful shift is underway in the travel industry. Travelers are increasingly bypassing traditional travel ads, influencer lists, and crowded attractions—opting instead for local-led discovery…
Finalist for the Polished Perfection Award. ReGlow to Sponsor and Exhibit at 1 Hotel South Beach. Winners Announced March 28, 2026. This recognition affirms our mission to deliver a refined,…
This appointment strengthens the organization’s capacity to build global partnerships, expand youth initiatives, and achieve broader, lasting community impact. DANIEL, WY, UNITED STATES — The Trueness Project is proud to announce the…
Tiffany C. Jacobs delivers a faith-centered guide that validates spiritual wounds, restores hope, and helps readers rebuild trust without walking away from God. Tiffany C. Jacobs addresses one of the…
Production-ready AI infrastructure for regulated, air-gapped, and mission-critical environments Cannes, France –– Understand Tech today announced the launch of AI-In-a-Box, a production-ready enterprise AI platform designed to run entirely inside…
Boynton Beach, Fla. — Barasch & McGarry is proud to announce that Managing Partner Michael Barasch alongside Ret. FDNY Deputy Chief Rich Alles will be guest speakers at The New…
SCHAUMBURG, IL, ISSUED — Pulse Technology (https://pulsetechnology.com), a seven-decade family business serving the IT, Managed Print Services, Audio-Visual and other technology needs of businesses throughout the Midwest and beyond, announced…
Axon Neuroscience’s active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer’s disease phase 2 clinical trial (supported by a USD 151…